| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | QL-XI-92 | GDSC1000 | pan-cancer | AAC | -0.071 | 0.02 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | 0.1 | 0.02 |
| mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | -0.083 | 0.02 |
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | -0.073 | 0.02 |
| mRNA | LAQ824 | GDSC1000 | pan-cancer | AAC | -0.078 | 0.02 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.086 | 0.03 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | 0.13 | 0.03 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | -0.08 | 0.03 |
| mRNA | GDC-0449 | GDSC1000 | pan-cancer | AAC | 0.081 | 0.03 |
| mRNA | SZ4TA2 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.03 |